Sun Pharma's US arm receives subpoena in antitrust probe

30 May 2016 Evaluate

Sun Pharmaceutical Industries’ US subsidiaries, Sun Pharmaceutical Industries Inc (SPII), has received a grand jury subpoena from the anti-trust division of the US Department of Justice seeking documents from the company and its affiliates relating to corporate and employee records, generic products and pricing, communications with competitors and others regarding the sale of generic pharmaceutical products. The company is responding to the Justice Department's subpoena, and the outcome of the inquiry was unlikely to have any adverse material impact on operations or financial results.

Sun Pharma is the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. Its global presence is supported by 49 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×